DOCS Share Price Performance
US$0
-76.99 (-100.00%)
Price US$0
Fair ValueUS$63.57
Share Pricen/a
Doximity, Inc. Stock Price
- 3 Narratives written by author
- 1 Comments on narratives written by author
- 83 Fair Values set on narratives written by author
DOCS Community Narratives
AN
Fair Value US$63.57 60.6% undervalued intrinsic discount
DOCS: Pharma Advertising Shift And AI Expansion Will Drive Measured Opportunity And Risks
1users have liked this narrative
1users have commented on this narrative
38users have followed this narrative
AN
Fair Value US$68.9 63.7% undervalued intrinsic discount
Digital Transformation And Telehealth Will Revolutionize Healthcare Collaboration
0users have liked this narrative
0users have commented on this narrative
2users have followed this narrative
AN
Fair Value US$50 50.0% undervalued intrinsic discount
Privacy Rules Will Squeeze Margins While Tools Will Support Recovery
0users have liked this narrative
0users have commented on this narrative
2users have followed this narrative
Digital Transformation And Telehealth Will Revolutionize Healthcare Collaboration
Key Takeaways Expansion of workflow modules and AI tools is driving platform growth, increasing user engagement, and bolstering high-margin SaaS opportunities. Strong industry tailwinds and leading clinician network position the company for sustained market share gains and recurring, higher-margin revenue streams.Read more
77
users have viewed this narrative0users have liked this narrative
0users have commented on this narrative
2users have followed this narrative
AN
US$68.9
63.7% undervalued intrinsic discount
AnalystHighTarget's Fair Value
Revenue
11.27% p.a.
Profit Margin
31.19%
Future PE
56.03x
Price in 2029
US$87.12
DOCS: Pharma Advertising Shift And AI Expansion Will Drive Measured Opportunity And Risks
Key Takeaways AI-powered workflow tools and high platform engagement drive deeper customer retention, higher revenue per user, and expanding long-term margins. Broad client demand and digital marketing trends position Doximity for sustained growth, improved sales efficiency, and earnings stability through diversified revenue streams.Read more
352
users have viewed this narrative1users have liked this narrative
1users have commented on this narrative
38users have followed this narrative
AN
US$63.57
60.6% undervalued intrinsic discount
AnalystConsensusTarget's Fair Value
Revenue
10.16% p.a.
Profit Margin
35.49%
Future PE
51.93x
Price in 2029
US$80.74
Privacy Rules Will Squeeze Margins While Tools Will Support Recovery
Key Takeaways Rising compliance costs, platform fatigue, and stronger competition may compress margins and threaten Doximity's core revenue growth. Shifts in client digital marketing budgets and the move to integrated health IT platforms could increase customer churn and limit user expansion.Read more
17
users have viewed this narrative0users have liked this narrative
0users have commented on this narrative
2users have followed this narrative
AN
US$50
50.0% undervalued intrinsic discount
AnalystLowTarget's Fair Value
Revenue
9.85% p.a.
Profit Margin
35.25%
Future PE
45.1x
Price in 2028
US$61.81
Trending Discussion
Recently Updated Narratives
AN
DOCS: Pharma Ad Shift And Share Buybacks Will Drive Shares Higher
Fair Value: US$68.9 63.7% undervalued intrinsic discount
2 followersusers have followed this narrative
0 commentsusers have commented on this narrative
0 likesusers have liked this narrative
AN
DOCS: Rebased Sentiment And Strong Moat Will Support Future Engagement
Fair Value: US$63.57 60.6% undervalued intrinsic discount
38 followersusers have followed this narrative
1 commentusers have commented on this narrative
0 likesusers have liked this narrative
AN
Privacy Rules Will Squeeze Margins While Tools Will Support Recovery
Fair Value: US$50 50.0% undervalued intrinsic discount
2 followersusers have followed this narrative
0 commentsusers have commented on this narrative
0 likesusers have liked this narrative
Snowflake Analysis
Doximity, Inc. Key Details
About DOCS
- Founded
- 2010
- Employees
- 830
- CEO
- WebsiteView website
Doximity, Inc. operates as a digital platform for medical professionals in the United States. Its platform provides its members with digital tools built for medicine, that enables its members to collaborate with colleagues, stay up to date with the latest medical news and research, manage their careers and on-call schedules, streamline documentation and administrative paperwork, and conduct virtual patient visits. The company primarily serves physicians, nurse practitioners, physician assistants, medical students, pharmaceutical manufacturers, and healthcare systems. The company was formerly known as 3MD Communications, Inc. and changed its name to Doximity, Inc. in June 2010. Doximity, Inc. was incorporated in 2010 and is headquartered in San Francisco, California.
